Anwendung des Toxin-Bindungs-Inhibitionstests zur Wirksamkeitsprüfung von Clostridium-novyi-Typ-B-Alphatoxoid-Impfstoffen

Luick, K.; Gottschaldt, J.; Schulze, Frank GND; Werner, E.; Erler, W.; Borrmann, Erika GND

The toxin binding inhibition test (ToBI) were developed for potency testing of C. novyi type B alpha toxoid containing veterinary vaccines to replace the currently used toxin neutralisation test in mice (TNT). The antitoxin titres of rabbit sera (AN-, HV- and SP sera) were determined with ToBI using the international reference serum with known antitoxin titre. In order to show the validity of the methods, the results were compared with those of the manufacturers/regulatory authorities and correlation coefficients were calculated. The correlation coefficients were r = 0.93 (AN sera), r = 0.73 (HV sera) and r = 0.85 (SP sera). All correlations were statistically significant. The specificity of the methods could be proved using heterologous antisera. The results of the ToBI were reproducible. Thus, the ToBI offers a suitable in vitro method for the determination of the antitoxin titre of rabbit antisera as an alternative to the toxin neutralisation in mice for potency testing of vaccines containing C. novyi type B alpha toxoid

Files

Cite

Citation style:

Luick, K. / Gottschaldt, J. / Schulze, Frank / et al: Anwendung des Toxin-Bindungs-Inhibitionstests zur Wirksamkeitsprüfung von Clostridium-novyi-Typ-B-Alphatoxoid-Impfstoffen. 2002.

Rights

Use and reproduction:
All rights reserved

Export